Skinner Jon's Form 4 filing
Pulse Biosciences, Inc. (PLSE) · filed Aug 28, 2026
- Accession no.
- 0001437749-26-029220
- Filed
- Aug 28, 2026, 7:17 PM ET
- Trade date
- Feb 3, 2025
- Filing delay
- 571 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 derivative transaction. It was filed 571 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Skinner JonCIK 0002078637 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Common Stock | AGrant or awardAcquired | +300,000 | $0.00 | $0 | 300,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.